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Abstract 
Objective: To investigate the factors associated with discrepancies between patient and 
caregiver reports of the quality of life of patients (QoLp) with Alzheimer’s disease (AD). 
Methods: Cross-sectional analytic study of 141 patients and their caregivers. The instruments 
used were the Quality of Life in AD (QoL-AD), the Global Deterioration Scale (GDS), the 
Geriatric Depression Scale (GDS-d) and the Anosognosia Questionnaire—Dementia (AQ-D). 
Differences were analyzed according to GDS stage. A linear regression analysis was 
conducted using the difference between the absolute QoLp scores of patients and caregivers. A 
cluster analysis involving the patient variables was then performed. Results: The discrepancy 
between patient and caregiver QoLp ratings increased in line with GDS stages (χ2 (2) = 8.7, p 
= 0.013). In the regression model (F [7,133] = 16.6, p <0.001; R2 = 0.477), discrepancies in 
QoLp reports were associated with greater anosognosia, less depression and a better cognitive 
status in patients, as well as with female gender among caregivers. The cluster analysis 
showed that patients with the lowest ratings of QoLp had a better cognitive status, more 
depression and less anosognosia. Conversely, the highest ratings were given by patients with a 
poorer cognitive status, less depression and greater anosognosia. Conclusions: The factors 
associated with greater discrepancies between patient and caregiver ratings of QoLp were 
severity of dementia, anosognosia, depression and cognitive status in patients, and female 
gender in caregivers. In patients with advanced dementia, greater anosognosia leads to more 
positive ratings in QoLp and complementary observations are required. 
Key words: Quality of life, depression, anosognosia, severity of dementia, patients, 
caregivers.  
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The assessment of quality of life is now widely included in clinical guidelines for the 
treatment of patients with dementia. Indeed, the Group for Harmonization of Dementia Drug 
Guidelines and the Alzheimer’s Society (1) recommend that not only the patient’s but also the 
relatives’ and professionals’ perceptions of the patient’s quality of life be considered when 
evaluating the effectiveness and appropriateness of therapeutic interventions. 
In recent years an increasing number of studies have examined the factors related to the 
perceived quality of life of patients (QoLp) with Alzheimer’s disease. (AD) This research has 
shown that in patients higher depression scores, (2-4) the presence of behavioral disorders (5-
7) and greater functional deficits (8, 9) all have negative effects on QoLp. Among caregivers, 
poorer ratings of QoLp have been shown to be associated with functional deficits (10, 11) and 
behavioral disorders (3, 9) in the patient and with burden (3) and depression (12, 13) in the 
caregiver. Some authors have also reported that perceptions of QoLp are affected by socio-
demographic and contextual factors such as the caregiver’s gender (14), his or her relationship 
to the patient, (15-17) the patient’s place of residence (2, 3) or the environmental conditions. 
(18)  
Although the assessment of QoLp may be a valid and reliable indicator at any stage of the 
disease there are certain aspects which require careful consideration. One of the most 
important in this regard concerns the large discrepancy between patient and caregiver reports 
of quality of life, (3, 19) this being particularly notable as the severity of dementia increases; 
(12-20) other factors to consider in this regard are the influence of depression (21) and reduced 
awareness of deficits (anosognosia) in the patient. (22-26)  
In light of the above the aims of the present study were as follows: 1) to determine the 
influence of severity of dementia, depression and anosognosia as regards the discrepancies 
between patient and caregiver reports of QoLp; and 2) to identify specific groups of patients 
associated with these discrepancies.  
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METHODS 
Design and study population 
Design: The design was an observational, cross-sectional and analytic study. 
Study population: A consecutive sample was recruited from among out-patients seen at 
the Dementia Unit of the Neurology Service of the Bellvitge University Hospital (Hospitalet 
de Llobregat, Spain). They were all diagnosed as either AD according to DSM-IV (Diagnostic 
and Statistical Manual of Mental Disorders) criteria (27) or probable AD according to 
NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and 
Stroke / Alzheimer’s Disease and Related Disorders Associations) criteria, (28) and had a 
score on the Mini-Mental State Examination (MMSE) (29) of between 10 and 28. The sample 
also comprised their respective family caregivers. The main caregiver was defined as the 
person who was responsible for helping the patient with activities of daily living (ADL). 
Patients were excluded if they had severe communication problems that prevented them from 
responding adequately to the assessment questions. The study was approved by the hospital’s 
Clinical Research Ethics Committee.  
Instruments 
Clinical and socio-demographic data. Socio-demographic data for patients and caregivers 
were gathered using an ad hoc structured questionnaire. 
Measure of quality of life. The Quality of Life—Alzheimer Disease (QoL-AD) scale (30) 
is designed to assess the patient’s quality of life (QoLp) from both the patient’s and the 
caregiver’s perspective. It is administered to both patients and caregivers and comprises 13 
items that refer to different aspects of the patient’s wellbeing. Scores for each item range from 
1 (poor) to 4 (excellent), yielding a total score between 13 and 52; the higher the score, the 
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better the quality of life. The scale’s authors considered that it was valid for patients with 
MMSE scores >10. 
Stage of dementia. The criteria applied here were those of the Global Deterioration Scale 
(GDS). This is a clinical assessment scale designed to determine the stage of a patient’s 
dementia. (31) 
Depression in the patient and the caregiver. The Geriatric Depression Scale (GDS-d), in 
its 15-item format, (32) was directly and independently administered to both patients and 
caregivers. The cut-off score for probable depression is 6.  
Anosognosia. The Anosognosia Questionnaire-Dementia (AQ-D) (33) was administered 
to patients and caregivers. It comprises 30 items that refer to cognitive/functional deficits and 
personality changes, with each item being rated according to the frequency of occurrence, 
from 0 (never) to 3 (always). The total score therefore ranges from 0 to 90, with higher scores 
being indicative of greater anosognosia. The final score is derived by calculating the 
difference between caregiver and patient scores. The scale’s authors considered that 
anosognosia was present when this difference is ≥ 32. 
Cognitive assessment of the patient. This was based on MMSE), (29) a brief cognitive 
assessment whose score ranges from 0 to 30 (the lower the score the greater the cognitive 
deterioration). 
Functional assessment of the patient. This was based on the Disability Assessment for 
Dementia (DAD), (34) a measure of basic and instrumental ADL. The DAD comprises 40 
items and its total score ranges from 40 to 80 (the higher the score the greater the functional 
capacity).  
Behavioral and psychological symptoms of dementia (BPSD). This aspect was assessed by 
means of the Neuropsychiatric Inventory (NPI), (35) which comprises twelve subscales that 
assess the frequency and severity of twelve neuropsychiatric symptoms. In the present study 
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this assessment was based on information provided by caregivers. Scores range from 0 to 144, 
and the higher the score the greater the frequency and severity of behavioral disorders.  
Physical and mental health of caregivers. This was assessed using the abbreviated version 
of the SF-36 Health Survey, (36) a twelve-item instrument whose total score ranges from 12 to 
28. It yields two global dimensions, physical and mental, on each of which the possible score 
ranges from 0 to 100 (the higher the score the better the respondent’s health).  
Caregiver burden. This was assessed using the Caregiver Burden Interview (CBI), (37) 
which comprises 22 items that are scored on a Likert scale ranging from 1 (never) to 5 (almost 
always). The total score therefore ranges between 22 and 110, and the higher the score the 
greater the burden. 
Procedure 
Neurologists from the Dementia Unit identified eligible patients according to the inclusion 
criteria and determined their degree of dementia in terms of GDS stage. (31) The sample was 
recruited between January and October 2011. Of the total number of patients who met the 
inclusion criteria only four families declined to participate.  
In the initial study interview the aims of the research were explained to patients and 
caregivers, and informed consent was obtained from all participants. Patients and their 
caregivers were then interviewed separately by two psychologists trained in the administration 
of the respective tests and instruments.  
Statistical analysis 
A descriptive analysis was carried out of the clinical and socio-demographic 
characteristics of the sample, using absolute and relative frequencies for qualitative variables 
and measures of central trend and dispersion for quantitative variables. 
The influence of clinical and socio-demographic variables on the QoL-AD scores of 
patients and caregivers was analyzed by means of parametric tests [ANOVA (F) and the 
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Student’s test (t)], non-parametric tests [Mann Whitney U (z) and Kruskal-Wallis (χ2)], and 
Pearson (r) and Spearman (rs) correlations, in accordance with criteria of normality. Pearson’s 
chi-square test was used for categorical variables. When there was a significant difference 
between two measures Cohen’s (d) was calculated in order to determine the effect size.  
The degree of agreement between patients and caregivers on the QoL-AD was assessed by 
calculating the corresponding correlation and the intraclass correlation coefficient (ICC). 
Discrepancies between patient and caregivers ratings on the QoL-AD were measured by 
taking into account their absolute scores.  
In order to analyze the influence of severity of dementia we compared QoL-AD scores 
and associated patient and caregiver factors across the different GDS stages.  
The patient and caregiver factors that were related to discrepancies in QoL-AD scores 
were determined through three linear regression analyses using the Enter method (introducing 
all the variables in a single step). The dependent variables were the QoL-AD scores of the 
patient and caregiver and the difference between them (patient-caregiver), while the 
independent variables were the clinical and socio-demographic factors. The coefficient of 
contribution for each variable was calculated by means of the solution suggested by Guilford 
and Fruchter: (38) beta coefficient x the coefficient of correlation with the dependent variable.  
Two-step cluster analysis was then used to identify groups of patients with homogeneous 
characteristics, introducing the patient variables that were significant in the linear regression 
analysis and comparing the resulting groups. 
For hypothesis contrasts the level of statistical significance was set at 0.05. All data 
processing and analysis was performed using SPSS version 17.0 for Windows.  
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RESULTS 
Description of the sample 
The final study sample comprised 141 patients and their respective caregivers. Twenty-
four of the initial cases (n = 165) were excluded: in 14 cases only the family caregiver could 
be interviewed, in one case only the patient could be interviewed, and in nine cases the patient 
had an MMSE score below 10. 
The mean age of patients and caregivers was, respectively, 77.6 years (SD = 7.2) and 63.2 
years (SD = 13.4). Eighty-three patients (58.9%) and 101 caregivers (71.6%) were women. 
Seventy-five of the caregivers (53.2%) were spouses and 58 (41.1%) were a child of the 
patient. A total of 118 caregivers (83.7%) lived with the patient. The socio-demographic data 
are shown in Table 1.  
Clinical data 
Patients. In terms of the severity of dementia, 57 patients (40.4%) met the criteria for 
GDS stage 4, 46 (32.6%) the criteria for GDS stage 5 and 38 (27.0%) the criteria for GDS 
stage 6. The mean depression score was 3.6 (SD = 2.9), while the mean anosognosia score was 
37.3 (SD = 19.9). The mean score on the NPI was 29.3 (SD = 21.2), with the most intense 
symptoms being apathy (mean = 5.7, SD = 4.4), irritability (mean = 3.6, SD = 4.1), anxiety 
(mean = 2.7, SD = 3.6) and aggressiveness (mean = 2.6, SD = 3.5).  
Caregivers. The mean score on the CBI was 51.9 (SD = 16.1), while that for depression 
(GDS-d) was 4.6 (SD = 3.6). 
The remaining clinical characteristics of patients and caregivers are presented in Table 2.  
Global ratings of the patient’s quality of life 
There were significant differences between the QoLp scores of patients (mean = 34.8, SD 
= 4.9) and caregivers (mean = 26.6, SD = 5.6) (Student's t = 14.5, df = 140, p <0.001; d = 1.5). 
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The ICC values were low in relation to measures of both absolute agreement (ICC = 0.18; df = 
140, 95%CI = -0.12, 0.42) and consistency (ICC = 0.35; df = 140, 95%CI = 0.10, 0.53).  
The only socio-demographic variable that showed differences as regards global QoLp 
scores was caregiver gender, with men giving higher QoL-p ratings than women (mean = 28.1, 
SD = 5.4, vs. mean = 26, SD = 5.6; Student's t = 2.0, df = 139, p = 0.046; d = 0.38). There 
were no significant differences in relation to kinship or living arrangements. 
Severity of dementia and quality of life 
There were no significant differences in patient reports of QoLp across different GDS 
stages, whereas caregivers reported poorer QoLp as severity increased. The discrepancy 
between patient and caregiver scores increased in line with the severity of dementia (GDS 
stages). 
The clinical factors of patients showed a clear deterioration as severity increased, with a 
reduction in cognitive and functional ability and an increase in neuropsychiatric symptoms on 
the NPI, especially apathy (Kruskal-Vallis, χ2 = 25.5, df = 2, p <0.001), disinhibition (Kruskal-
Vallis, χ2 = 16.7, df = 2, p <0.001) and euphoria (Kruskal-Vallis, χ2 = 16.0, df = 2, p <0.001).  
Among caregivers, increasing severity of dementia was associated with greater depression, 
burden as well as with poorer mental health (Table 3).  
Depression, anosognosia and quality of life according to GDS stage 
Higher depression scores among patients were correlated with poorer perceived QoLp at all 
GDS stages. Depression in caregivers was also globally correlated with a poorer perception of 
QoLp by the caregiver, but was not significant at any one GDS stage. 
Higher anosognosia scores among patients were correlated with better perceived QoLp, 
which remained high across the GDS stages. Conversely, for caregivers greater anosognosia in 
the patient was inversely correlated with QoLp, especially at GDS stages 4 and 5.  
  10
Anosognosia and depression were inversely correlated among patients, especially in the 
early stages. For caregivers there was a direct correlation between anosognosia and 
depression, which only reached significance at GDS stage 6.  
The common factor among patients and caregivers was the correlation between greater 
depression and poorer perceived QoLp. The differential factors were the opposing directions 
of the correlations between anosognosia and QoLp (direct in patients and inverse in 
caregivers) and between anosognosia and depression (inverse in patients and direct in 
caregivers) (Table 3).  
Multivariate linear regression analysis 
The regression model for QoLp ratings by patients showed that greater anosognosia and 
less depression were the main variables associated with higher scores. The regression model 
for caregiver ratings of QoLp showed that better ratings were associated with less caregiver 
burden and with the following patient factors: less anosognosia, less depression and greater 
functional ability in ADL (Table 4). 
The regression model for the differences in QoLp scores between patients and caregivers 
revealed that the factors showing the greatest positive discrepancy were anosognosia and the 
MMSE score; in both cases patients scored higher than caregivers. The factor that showed the 
greatest negative discrepancy was depression in the patient, with patients scoring lower than 
caregivers. The only caregiver factor associated with discrepancies was gender, with women 
scoring lower than men. 
Clusters of patients and caregivers: associated factors 
When the patient variables that were significant in the linear regression analysis of 
differences in QoLp scores were introduced into the two-step clustering procedure, two more 
homogeneous groups were identified (Table 5). The clusters revealed differences in relation to 
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two patient variables, namely QoLp and GDS-d, which did not show differences in the initial 
analysis based on GDS stages. 
Comparison of the two clusters revealed that patients in the first group had a better 
cognitive status, fewer neuropsychiatric symptoms and greater functional ability. In other 
words, their capacities were better preserved. However, patients in this first cluster also 
presented more depression, less anosognosia and gave worse ratings of QoLp, compared to 
those in the second group.  
Caregivers of patients in the first cluster presented less depression, better mental health and 
less burden, and also gave better ratings of QoLp 
 
DISCUSSION AND CONCLUSION 
Severity of dementia and patients’ quality of life 
The results of the study show that patients’ own ratings of their quality of life (QoLp) 
remained stable in GDS stages despite increasing severity of dementia and greater cognitive, 
functional and behavioral deterioration. By contrast, caregiver ratings of QoLp were more 
consistent with the clinical data, decreasing as the severity of dementia increased.  
The QoLp ratings of less deteriorated patients were more in line with those of caregivers, 
with the discrepancy becoming greater as the patient deteriorated further. The observed 
stability in patients’ ratings of QoLp (39, 40) and the decreasing ratings among caregivers has 
been widely reported. (13, 20)  
Quality of life of patients in the analysis of clusters 
The cluster analysis identified two groups of patients with different degrees of 
deterioration. The only difference between the analysis based on GDS stages and the cluster 
analysis was that the latter revealed significant differences for the patient variables QoLp and 
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depression. This indicates that an approach based on the severity of dementia according to 
GDS stage is valid when the aim is to observe discrepancies between patients and caregivers. 
However, if we wish to assess how patient scores evolve we should also include the patient 
variables anosognosia and depression, alongside the variables related to cognitive, functional 
and behavioral deterioration. In this regard, the cluster analysis identified two groups of 
patients with different characteristics and perceptions in relation to QoLp ratings.  
Depression, anosognosia and quality of life 
The cluster analysis shows that patients with mild deterioration presented less 
anosognosia, more depression and a QoLp rating that was closer to that of caregivers. This 
pattern of results was reversed among more deteriorated patients.  
The data show that depression in the patient is associated with more negative ratings of 
QoLp. The influence of depression is one of the most consistent findings in published 
research. (2-4) 
Among patients the presence of anosognosia was associated with better ratings of QoLp 
and with greater severity. As regards the latter the results are consistent with previous studies 
that have reported greater anosognosia with greater severity of dementia, older age and more 
deficits in ADL. (41, 42)  
In the present study, depression and anosognosia were inversely correlated among 
patients. Previous research has produced contradictory findings regarding the relationship 
between depression and anosognosia: whereas some authors have reported greater depression 
among anosognosic patients (42) others have, in line with the present data, found an inverse 
correlation between depression and anosognosia in the early stages. (43, 44)  
Discrepancies between patient and caregiver ratings of the patient’s quality of life 
A number of hypotheses can be put forward to explain the discrepancies between patient 
and caregiver ratings of the patient’s quality of life:  
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Adaptation mechanism. The observed stability in patient ratings of QoLp could be an 
adaptation mechanism. Indeed, the disability paradox, whereby self-concept remains stable 
despite disabilities, is well documented. (45) Doubts arise, however, in relation to AD because 
the cognitive deterioration may be severe in the advanced stages of the disease. The suggestion 
that patient and caregiver perceptions constitute two unique and different views, both 
potentially valid, could be included within this perspective. (22, 45) 
Amnesic anosognosia. According to this hypothesis the self-evaluation of patients would 
be based erroneously on information stored in their memory. As their recent memory 
deteriorates further they would find it increasingly difficult to offer a reliable and up-to-date 
description of their capacities and health status. (46) Stability in patient ratings of QoL, 
regardless of their actual cognitive deterioration, would support this observation. 
Executive anosognosia. This hypothesis is complementary to the former. The presence of 
anosognosia would be associated a deficit in executive capacity, i.e. the patient’s ability to 
analyze and evaluate his or her own situation. A lack of awareness of one’s deficits would 
account for the stability in patient ratings of QoLp in advanced stages of dementia. Various 
authors have pointed out the advisability of relativizing patients’ own appraisals of their 
quality of life when anosognosia is present. (22-24)   
Anosognosia, as a factor present in AD, can bring an interesting perspective to the 
analysis of quality of life. It should be noted, however, that other factors which may affect 
patient and caregiver ratings of QoLp have also been reported. Noteworthy among these are 
depression in the patient, (2-4) the family relationship between patient and caregiver, (15-17) 
the patient’s place of residence (2, 3) and environmental factors .(18)  
If the concept of ‘the patient’s quality of life’ is to be useful in verifying the 
appropriateness of therapeutic interventions then any evaluation should, as Mack and 
Whitehouse (1) point out, take into account not only the inherent features of the disease 
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(cognitive and functional deterioration) but also associated factors (anosognosia, depression) 
and contextual aspects (family and social environment).  
Conclusions 
1.  Patient ratings of QoLp remained stable across the stages of dementia, despite the fact that 
the clinical data showed a progressive deterioration.  
2. Anosognosia was associated with a more positive self-appraisal among patients and its 
presence increased as AD evolves. In the early stages of the disease it was inversely 
correlated with depression.  
3. Caregiver ratings of QoLp were lower than those of patients, although the difference 
between the two was less in the early stages of dementia.  
4. Caregiver ratings of QoLp decreased as anosognosia worsened, as the dementia became 
more severe, and as functional deficits increased. 
5.  The factors associated with a greater discrepancy between patient and caregiver ratings of 
QoLp were the severity of dementia, anosognosia, depression and cognitive status in 
patients, and female gender among caregivers. 
Clinical Implications. Patients’ own ratings of their quality of life should be 
complemented with measures of anosognosia and depression. Depression in the patient 
alongside a greater awareness of deficits (less anosognosia) may lead to a more negative 
appraisal of QoL, especially in the early stages of the disease. Treatment of such depression in 
the early stages could lead to an improved perception of quality of life. In the later stages the 
presence of greater anosognosia may produce an overly positive view of QoL-p, and the 
patient’s report should therefore be complemented with other non-verbal observations, as well 
as with information provided by the caregiver. Caregiver burden should be assessed at all 
stages of the disease as it may bias caregiver ratings of quality of life and anosognosia. (47) 
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Attention should also be paid to caregivers’ needs for practical guidance and emotional 
support, as such input could lead to a greater understanding and acceptance of their relative’s 
disease.  
The study has a number of limitations. Firstly, the educational level of caregivers was low 
and this may have influenced their (low) ratings of QoLp. A further limitation concerns the 
lack of data about a possible history of depression in patients, as this would have helped 
provide a better understanding of the depression factor. Finally, information was lacking about 
the quality of the previous and current relationship between patients and caregivers, this being 
an aspect that would likely affect the ratings of QoLp.  
This study was conducted within the framework of the project Assessing perceptions of 
patient quality of life in patients with Alzheimer’s disease and their family caregivers over a 
two-year period, funded by Spain’s Ministry of Science and Innovation (Ref. PSI2010-19014). 
The authors are also grateful for the support given to this study by the town council of 
Hospitalet de Llobregat. Thanks are due to the psychologists Laura Moreno-Cordón and 
Vanesa Viñas-Diez for their work in test administration and data collection, and also to the 
psychiatrist Dr. Joan Vilalta-Franch for his help with methodological and statistical aspects 
of the study.  
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 TABLE 1.  Socio-demographic characteristics of the participants 
 Patients (N = 141) Caregivers (N = 141) 
 Age, years    Age, years  
  Mean (SD) 77.6 (7.2)  Mean (SD)  63.2 (13.4) 
  Median (IQR) 78.5 (74.3-82.4)  Median (IQR)  62.7 (52.2-76.0) 
 Gender, n (%)   Gender, n (%) 
  Female 83 (58.9)  Female 101 (71.6) 
 Marital Status, n (%)   Marital Status, n (%) 
  Married                     95 (67.4)  Married  116 (82.4) 
  Widowed 43 (30.5)     Widowed    4 (2.8) 
  Single  3 (2.1)    Single   16 (11.3) 
  Divorced  -----    Divorced    5 (3.5) 
 Level of education, n (%)   Level of education, n (%) 
  Illiterate / no schooling  59 (41.9)  Illiterate / no schooling  22 (15.6) 
  1-4 years 27 (19.1)  1-4 years  14 (9.9) 
  5-8 years  39 (27.7)  5-8 years   48 (34.1) 
  > 8 years 16 (11.3)   > 8 years   57 (40.4) 
     Family relationship, n (%)   
      Spouse  75 (53.2) 
      Son / daughter   58 (41.1)  
     Other relative   8 (5.7)  
   Living with the patient, n (%) 
    Yes 118 (83.7) 
 IQR = Interquartile range 
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TABLE 2.  Clinical factors of participants 
Patients (N = 141) Mean (SD)  Median (IQR) 
 QoL-AD (quality of life) 34.8 (4.9)  
 MMSE (cognition) 17.6 (5.9)   
 AQ-D (anosognosia)   37.3 (19.9) 
  ≥ 32 points, n (%)  79 (56.0) 
 GDS-d (depression)  3.6 (2.9) 3.0 (1.0-6.0) 
  ≥ 6 points, n (%) 43 (30.5) 
 DAD (function, ADL) 55.7 (10.2) 55.0 (47.0-64.5)  
 NPI (behavior) 29.3 (21.2) 25.0 (13.5-38.5)  
Caregivers (N = 141) Mean (SD)  Median (IQR) 
 QoL-AD (quality of life of patients) 26.6 (5.6)  
 CBI (burden)  51.9 (16.1)  
 SF-12 (health)  
  Physical  47.8 (11.0) 51.8 (40.1-56.2)  
  Mental  42.6 (12.8) 46.1(31.2-53.0) 
 GDS-d (depression) 4.6 (3.6)  4.0 (2.0-7.0) 
  ≥ 6 points, n (%) 43 (30.5) 
 Hours/day (care time) 6.9 (4.1)  6.5 (3.1-12.0) 
IQR = Interquartile range 
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 TABLE 3.  Quality of life of patients and patient/caregiver factors in relation to GDS stage  
 GDS 4 (n = 57) GDS 5 (n = 46) GDS 6 (n = 38) 
 Mean (SD) Mean (SD) Mean (SD) F / χ2 p 
QoL-AD  
 Patients 35.4 (4.8) 34.3 (4.5) 34.4 (5.5)  0.7  0.491 a 
 Caregivers 29.4 (5.9) c 25.6 (4.2)  23.6 (5.0) e 15.3 <0.001 a 
 Patients-Caregivers (diff.)  7.3 (5.8) 8.9 (5.2) 10.7 (5.9) e  8.7  0.013 b 
Patient factors  
 MMSE (cognition)  20.8 (4.8) c 17.2 (5.1) d 13.1 (5.4) e 25.6  <0.001 a 
 NPI (behavior) 19.3 (15.2) c 32.7 (21.6)  40.4 (22.1) e 29.6 <0.001 b 
 DAD (function, ADL) 65.3 (6.4) c 52.6 (5.9) d 44.9 (4.2) e 96.7 <0.001 b 
 GDS-d (depression)  3.7 (2.9)   3.6 (2.8)   3.6 (3.1)  0.1  0.948 b 
 AQ-D (anosognosia)   24.6 (17.2) c 41.5 (14.9) d 52.4 (16.6) e 33.9 <0.001 a 
Caregiver factors  
 SF-12 (physical health) 48.1 (10.6) 46.9 (11.9) 48.5 (10.8)  0.3  0.836 b 
 SF-12 (mental health) 45.8 (11.8) 41.5 (12.4) 39.2 (13.9)   7.2  0.026 b 
 CBI (burden)  45.0 (13.0) c 56.1 (16.6) 57.1 (16.3) e  9.8 <0.001 a 
 GDS-d (depression)  3.4 (2.9)  4.9 (3.5)  5.8 (4.1) e  9.9   0.007 b 
 Hours/day care ADL  5.3 (4.3) c  6.8 (3.5) d 9.4 (3.0) e 24.8 <0.001 b 
   r /rs p  r / rs p  r / rs p r / rs p 
Correlations in patients        
 AQ-D / QoL-AD  0.54 <0.001  0.38  0.010  0.44 0.007  0.31 <0.001 f 
 AQ-D / GDS-d  -0.46 <0.001 -0.36  0.016 -0.32  0.050 -0.34 <0.001 g 
 QoL-AD / GDS-d  -0.65 <0.001 -0.57 <0.001 -0.56 <0.001 -0.61 <0.001 g 
Correlations in caregivers  
 AQ-D / QoL-AD  -0.48 <0.001 -0.39  0.008 -0.28 0.094 -0.56 <0.001 f  
 AQ-D / GDS-d   0.20  0.122  0.03  0.807  0.39 0.017  0.32 <0.001 g  
 QoL-AD / GDS-d  -0.16  0.223 -0.25  0.084 -0.05 0.731 -0.25   0.002 g 
 
a F = ANOVAs, (df = 2,138); b χ2 = Kruskal-Wallis, (df = 2); Significant with Bonferroni post-hoc = c 
Contrast GDS 4-5, d Contrast GDS 5-6, e Contrast GDS 4-6.  
f r = Pearson correlation coefficients, GDS 4 (df = 55), GDS 5 (df = 44), GDS 6 (df = 36), All cases (df = 
139) ; g rs = Spearman's correlation coefficients  
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TABLE 4.  Multivariate linear regression analysis. QoL-AD of patients, caregivers and 
differences 
   QoL-AD  QoL-AD Differences QoL-AD 
   Patients Caregivers (Patients-Caregivers)  
 R2 = 0.540 R2 = 0.574 R2 = 0.477  
 β        t  p  β t p β t p r  CC 
Patient Factors   
 AQ-D (anosognosia)  0.54  5.4 <0.001 -0.21 -2.2  0.029  0.50  4.6 <0.001  0.63
 31.9 
 GDS-d (depression)  -0.47 -7.0 <0.001 -0.18 -2.7  0.006 -0.17 -2.4  0.017 -0.32  5.7 
 MMSE (cognition)  0.15  2.3  0.023 -0.10 -1.6  0.093  0.17  2.3  0.019  0.00  0.2 
 NPI (behavior) -0.22 -2.5  0.011 -0.10 -1.2  0.209  0.00  0.0  0.988  0.40   0.0 
 DAD (function, ADL)  0.30  3.4  0.001  0.42  5.0 <0.001 -0.09 -0.9  0.342 -0.39  3.6 
Caregiver Factors  
 Gender   0.05  0.8  0.386 -0.05 -0.9 0.357  0.14  2.1  0.034  0.25  3.7 
 CBI (burden) -0.03 -0.4  0.690 -0.19 -2.5 0.012  0.07  0.8  0.389  0.36  2.6 
 
47.7 
ANOVA. QoL-AD patients, F = 21.4 (df = 7,133), p <0.001; QoL-AD caregivers, F = 24.6 (df = 7, 
133), p <0.001; Differences QoL-AD, F = 16.6 (df = 7, 133), p <0.001. 
R2 = Determination coefficient; β = standardized beta coefficient; r = Pearson correlation (zero-order), df 
= 139; CC = Coefficient of contribution (%), [(β. r) x 100]  
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TABLE 5.  Clusters showing significant factors for QoL-AD differences. 
 Cl.1, n = 59  Cl.2, n = 82     
 Mean (SD) Mean (SD) t / z p d 
QoL-AD 
 Patient  33.4 (5.1)  35.7 (4.6)   2.7  0.007 a 0.47 
 Caregiver  30.1 (5.1) 24.1 (4.6)  7.2 <0.001 a 1.23 
 Patient-Caregiver (diff.)   4.8 (3.7) 11.6 (5.3)  7.0 <0.001 b 1.48 
Patient factors  
 MMSE (cognition) 19.7 (5.6) 16.0 (5.7)  3.7  <0.001 a 0.65 
 NPI (behavior) 14.6 (9.8)  39.9 (20.9)   7.8 <0.001 b 1.55 
 DAD (function, ADL) 62.1 (10.0)  51.0 (7.5)   6.1 <0.001 b 1.25 
 GDS (stage 5-6), n (%) 17 (28.8) 67 (81.7) 37.6 <0.001 c 
 GDS-d (depression)  4.8 (3.1)   2.8 (2.5)   4.0 <0.001 b 0.71 
  ≥ 6 points, n (%) 26 (44.1) 17 (21.0)  7.4  0.006 c 
 AQ-D (anosognosia)   18.8 (11.7) 50.5 (12.7)  14.8 <0.001 a 2.59 
  ≥ 32 points, n (%)  5 (8.8) 74 (92.5) 92.1 <0.001 c 
Caregiver factors  
 SF-12 (physical health) 49.8 (9.7) 46.4 (11.8)  1.6  0.096 b  
 SF-12 (mental health) 47.0 (10.6) 39.4 (13.3)  3.6 <0.001 b 0.63 
 CBI (burden)  41.4 (11.0)  59.4 (14.9)  8.2 <0.001 a 1.34 
 GDS-d (depression)  3.2 (2.6)  5.5 (3.9)  3.6  <0.001 b 0.69 
  ≥ 6 points, n (%)  9 (15.3) 34 (41.5) 15.2 <0.001 c 
 Hours/day care   5.4 (4.1)   8.0 (3.7)   3.7 <0.001 b 0.66 
a  t = Student’s t test (df = 139); b z = Mann-Whitney U; c Pearson chi-square test with Yates' correction 
(categorical variables), (df = 1); d = Cohen's d.  
 
